MISCELLANEOUS PROVISIONS.

SEC. 256. MISCELLANEOUS PROVISIONS. (a) Public Health Emergency Fund.—Section 319 of the Public Health Service Act (42 U.S.C. 247d) is amended— (1) in subsection (a), by inserting “the Administrator of Health Resources and Services,” before “or the Director”; and (2) in subsection (b)(1), by striking “$30,000,000” the second place it appears and inserting in lieu thereof “$45,000,000”. (b) Certain Use of Funds.—None of the funds provided under this Act or an amendment made by this Act shall be used to provide individuals with hypodermic needles or syringes so that such individuals may use illegal drugs, unless the Surgeon General of the United States determines that a demonstration needle exchange program would be effective in reducing drug abuse and the risk that the public will become infected with the etiologic agent for acquired immune deficiency syndrome. (c) Report on Certain Ethical Issues.—The Congressional Biomedical Ethics Board shall report to Congress within eighteen months from the effective date of this Act on the ethical issues 102 STAT. 3111connected with the administration of nutrition and hydration to dying patients. This report shall include a review of State laws, regulations and court decisions on this topic. The report shall also discuss the arguments concerning the appropriate roles of the patient, the patient’s family, the care provider, the State and the appropriate Federal role. (d) Study of State Laws.— (1) The Secretary of Health and Human Services shall conduct a study for the purpose of determining— (A) the laws and policies of the States relating to confidentiality and disclosure of information with respect to records of the counseling and testing of individuals regarding the etiologic agent for acquired immune deficiency syndrome; and (B) the laws and policies of the States relating to discrimination against individuals infected with such etiologic agent or regarded as being so infected. (2) Not later than 6 months after the date of the enactment of this Act, the Secretary of Health and Human Services shall complete the study required in subsection (a) and submit to the Congress a report describing the findings made as a result of the study.